# ***In silico*** identification of CDK1 inhibitors in colorectal cancer



## Table of Contents
- [Introduction](#Introduction)
- [Objectives](#Objectives)
- [Methodology](#Methodology)
- [Results](#Results)
- [Conclusion](#Conclusion)
- [Team](#Team)
- [Acknowledgment](#Acknowledgment)
- [References](#References)
- [License](#License)


## Introduction

- 
- 

## Objectives
- To screen natural compounds against CDK1 and identify potential inhibitors using *in silico* approach
- To study the stability of the docked complexes using molecular dynamics simulation



## Methodology



## Results
-
-
-


## Conclusion
- The findings from the study suggest that the identified natural compounds could act as potential inhibitors against CDK1 for developing new therapeutics for colorectal cancer.

## Team 
- [Uchechukwu Chibuzo Ogbodo](https://github.com/uchechibuzo)
- [Halimat Chisom Atanda](https://github.com/chisomgold)
- [Ojochenemi Enejoh](https://github.com/chennymee)
- [Pauline Gachanja](https://github.com/paulinegachanja)
- [Shamim Osata](https://github.com/osatashamim)
- [Kenneth Okolo](https://github.com/kennethokolo)
- [Pranavathiyani G](https://github.com/pranavathiyani)


## Acknowledgment
- We thank **[African Society for Bioinformatics and Computational Biology (ASBCB)](https://www.asbcb.org/)** and **The National Institutes of Health Office of Data Science Strategy** for organizing the ***ASBCB Omics Codeathon*** providing the required support and resources.


## References


## License

Licensed under MIT License - Copyright (c) 2022 omicscodeathon (Refer LICENSE file for more details)
